![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Humira: Uses, Dosage, Side Effects, Warnings - Drugs.com
Humira is also used in adults and children to treat Crohn's disease, juvenile idiopathic arthritis, ulcerative colitis, and uveitis. Humira's mechanism of action involves specifically targeting and blocking tumor necrosis factor (TNF)-alpha, a key inflammatory protein in the immune system.
Humira: 7 things you should know - Drugs.com
Sep 21, 2023 · Humira does not cure inflammatory conditions; however, it does help relieve symptoms and may prevent disease worsening. Humira is an immunosuppressant and can lower the ability of your immune system to fight bacterial, viral, or fungal infections or make an infection worse. It may cause some infections, such as tuberculosis, to become active again.
Adalimumab: Uses, Dosage, Side Effects, Warnings - Drugs.com
Dec 10, 2024 · Humira was approved by the FDA on December 31, 2002. Humira was the first brand of adalimumab, so it is called the reference product. Biosimilars of Humira are now also available, see below for a full list of adalimumab biosimilars, indications, and companies.
Humira: Package Insert / Prescribing Information - Drugs.com
HUMIRA is intended for use under the guidance and supervision of a physician. A patient may self-inject HUMIRA or a caregiver may inject HUMIRA using either the HUMIRA Pen or prefilled syringe if a physician determines that it is appropriate, and with medical follow-up, as necessary, after proper training in subcutaneous injection technique.
Is Humira an immunosuppressant? - Drugs.com
May 13, 2024 · The manufacturer of Humira does not list weight gain or weight loss as a possible direct side effect associated Humira. However, other conditions, symptoms, or medications may affect your weight while you are using this medication. Clinical studies have also shown weight gain with Humira. Continue reading
Humira Dosage Guide - Drugs.com
Feb 1, 2024 · HUMIRA is intended for use under the guidance and supervision of a physician. A patient may self-inject HUMIRA or a caregiver may inject HUMIRA using either the HUMIRA Pen or prefilled syringe if a physician determines that it is appropriate, and with medical follow-up, as necessary, after proper training in subcutaneous injection technique.
Humira (adalimumab) FDA Approval History - Drugs.com
Aug 25, 2022 · Humira (adalimumab) is a recombinant human IgGl monoclonal antibody specific for human tumor necrosis factor (TNF) indicated for the treatment of plaque psoriasis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, psoriasis, juvenile idiopathic arthritis, ulcerative colitis, hidradenitis suppurativa, and ...
Adalimumab Side Effects: Common, Severe, Long Term - Drugs.com
Nov 22, 2024 · Humira (adalimumab) 80 mg/0.8 mL in a single-dose pen View larger images Drugs.com Mobile App Access drug & treatment information, identify pills, check interactions and set up personal medication records.
Humira Pen Uses, Side Effects & Warnings - Drugs.com
Humira Pen is used alone or in combination with certain medicines. Humira Pen is used to treat juvenile idiopathic arthritis in adults and children at least 2 years old. Humira Pen is also used for the treatment of Crohn's disease in adults and children at least 6 years old.
Humira Reviews & Ratings - Drugs.com
For Rheumatoid Arthritis "My father went on Humira for rheumatoid arthritis. He was diagnosed with non-Hodgkin's lymphoma 6 months later, and his rheumatologist took him off Humira immediately. His rheumatologist admitted that Humira caused the lymphoma. My father died a few months later. There is a black box warning that Humira may cause lymphoma.